跳至主要内容
临床试验/NCT03997838
NCT03997838已完成3 期

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled Trial to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty

Vivozon, Inc.5 个研究点 分布在 1 个国家目标入组 307 人开始时间: 2019年5月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Vivozon, Inc.
入组人数
307
试验地点
5
主要终点
Total Area Under the Curve (AUC) of Pain Intensity for 12 hours post-emergence

研究概览

简要总结

The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following abdominoplasty.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women between 18-70 years old, inclusive. Female subjects must meet additional criteria according to childbearing potential.
  • Planning to undergo abdominoplasty
  • Ability to provide written informed consent
  • Ability to understand study procedures and communicate clearly with the investigator and staff
  • American Society of Anesthesiologists (ASA) risk class of I to II.

排除标准

  • Emergency or unplanned surgery
  • Previous abdominoplasty
  • Pre-existing condition causing preoperative pain around the site of surgery
  • Women who are pregnant or breastfeeding
  • Chronic pain diagnosis and ongoing or frequent use of pain medications

研究组 & 干预措施

VVZ-149 Injections

Experimental

干预措施: VVZ-149 Injections (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Total Area Under the Curve (AUC) of Pain Intensity for 12 hours post-emergence

时间窗: 0-12 hours post-emergence

Using Numeric Pain Rating Scale (NRS, 0-10 at rest)

次要结局

  • Total number of requests for rescue medication for 24 hours post-emergence(0-24 hours post-emergence)
  • Total amount of rescue medication consumption for 12 hours post-emergence(0-12 hours post-emergence)
  • Proportion of patients who report mild pain (NRS 0-3) at each time point during 24 hours post-emergence(0-24 hours post-emergence)
  • Total amount of intra-operative fentanyl use(During surgery)

研究者

发起方
Vivozon, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Evaluate the Efficacy and Safety of VVZ-149... | 临床试验